Literature DB >> 15642401

Mutational analysis of hSNF5/INI1 and TP53 genes in choroid plexus carcinomas.

Magdalena Zakrzewska1, Izabela Wojcik, Krzysztof Zakrzewski, Lech Polis, Wieslawa Grajkowska, Marcin Roszkowski, Brian J Augelli, Pawel P Liberski, Piotr Rieske.   

Abstract

We report here the mutational analysis of hSNF5/INI1 and TP53 genes performed on 11 specimens of choroid plexus carcinomas (CPC) in which a large number of abnormalities has been detected by molecular biology techniques. Loss of heterozygosity (LOH) analysis performed on six tumors revealed losses on chromosomes 1, 3, 5, 9, 10, 13, 16, 18, and 22. However, there were no abnormalities on 17p and mutations of the TP53 gene have been observed for two tumors comprising exons 5 and 7, respectively. Exon 4 of hSNF5/INI1 was mutated in one tumor with LOH restricted to the hSNF5/INI1 locus. There was no coexistence of mutations in both analyzed genes. Our analysis confirms the presence of the hSNF5/INI1 mutations and proves involvement of TP53 mutations in sporadic cases of CPC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642401     DOI: 10.1016/j.cancergencyto.2004.05.002

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

Review 1.  Molecular genetics of pediatric central nervous system tumors.

Authors:  Nicole J Ullrich; Scott L Pomeroy
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

2.  Atypical teratoid rhabdoid tumors of the posterior fossa in children.

Authors:  Arthur J DiPatri; Simone Treiger Sredni; Gordan Grahovac; Tadanori Tomita
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

3.  Detection of P53 mutations in different cancer types is improved by cDNA sequencing.

Authors:  Sylwester Piaskowski; Izabela Zawlik; Malgorzata Szybka; Dominika Kulczycka-Wojdala; Ewelina Stoczynska-Fidelus; Michal Bienkowski; Tadeusz Robak; Renata Kusinska; Dorota Jesionek-Kupnicka; Radzislaw Kordek; Piotr Rieske; Pawel P Liberski
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

Review 4.  Current management of choroid plexus carcinomas.

Authors:  Matthew Z Sun; Michael C Oh; Michael E Ivan; Gurvinder Kaur; Michael Safaee; Joseph M Kim; Joanna J Phillips; Kurtis I Auguste; Andrew T Parsa
Journal:  Neurosurg Rev       Date:  2013-09-26       Impact factor: 3.042

5.  Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development.

Authors:  Yasumichi Kuwahara; E Lorena Mora-Blanco; Fatima Banine; Arlin B Rogers; Christopher Fletcher; Larry S Sherman; Charles W M Roberts; Bernard E Weissman
Journal:  Int J Cancer       Date:  2012-12-27       Impact factor: 7.396

6.  A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma.

Authors:  Sheng-Qing Lv; Ye-Chun Song; Jian-Ping Xu; Hai-Feng Shu; Zheng Zhou; Ning An; Qi-Lin Huang; Hui Yang
Journal:  Med Sci Monit       Date:  2012-05

7.  Choroid Plexus Tumors: Experience of 10 Cases with Special References to Adult Cases.

Authors:  Manoj Bohara; Masashi Hirabaru; Shingo Fujio; Michiyo Higashi; Hajime Yonezawa; Prasanna Karki; Ryosuke Hanaya; Hirofumi Hirano; Hiroshi Tokimura; Kazunori Arita
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-10-16       Impact factor: 1.742

8.  Mutations in SMARCB1 and in other Coffin-Siris syndrome genes lead to various brain midline defects.

Authors:  Alina Filatova; Linda K Rey; Marion B Lechler; Jörg Schaper; Maja Hempel; Renata Posmyk; Krzysztof Szczaluba; Gijs W E Santen; Dagmar Wieczorek; Ulrike A Nuber
Journal:  Nat Commun       Date:  2019-07-04       Impact factor: 14.919

9.  cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer.

Authors:  Malgorzata Szybka; Magdalena Zakrzewska; Piotr Rieske; Grazyna Pasz-Walczak; Dominika Kulczycka-Wojdala; Izabela Zawlik; Robert Stawski; Dorota Jesionek-Kupnicka; Pawel P Liberski; Radzislaw Kordek
Journal:  BMC Cancer       Date:  2009-08-11       Impact factor: 4.430

10.  Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53.

Authors:  M Szybka; I Zawlik; D Kulczycka; E Golanska; E Jesien; D Kupnicka; R Stawski; S Piaskowski; E Bieniek; M Zakrzewska; R Kordek; P P Liberski; P Rieske
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.